Princeton Global Asset Management LLC Abb Vie Inc. Transaction History

Princeton Global Asset Management LLC

$397 Million
Q1 2024

A detailed history of Princeton Global Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 29,068 shares of ABBV stock, worth $4.99 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

29,068

Previous 29,290 0.76%

Holding current value

$4.99 Million

Previous $4.54 Million 16.61%

% of portfolio

1.33%

Previous 1.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $35,480 - $40,426	-222 Reduced 0.76%	29,068 $5.29 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $174,064 - $196,037	-1,265 Reduced 4.14%	29,290 $4.54 Million
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $138,666 - $160,526	-1,038 Reduced 3.29%	30,555 $4.55 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $1.7 Million - $2.12 Million	-12,849 Reduced 28.91%	31,593 $4.26 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $35,140 - $40,469	-243 Reduced 0.54%	44,442 $7.08 Million

Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $13,692 - $16,421	99 Added 0.22%	44,685 $7.22 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $84,552 - $96,975	-630 Reduced 1.39%	44,586 $5.98 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $164,318 - $208,902	-1,194 Reduced 2.57%	45,216 $6.93 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $168,010 - $208,453	1,273 Added 2.82%	46,410 $7.52 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $69,614 - $88,082	648 Added 1.46%	45,137 $6.11 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $4.22 Million - $4.79 Million	39,690 Added 827.05%	44,489 $4.8 Million
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $4.37 Million - $4.96 Million	-41,077 Reduced 89.54%	4,799 $4.8 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $1.44 Million - $1.6 Million	13,648 Added 42.35%	45,876 $5.17 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $144,447 - $159,019	1,412 Added 4.58%	32,228 $3.49 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $37,910 - $51,183	471 Added 1.55%	30,816 $3.3 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $286,595 - $336,368	-3,336 Reduced 9.9%	30,345 $2.66 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $1.3 Million - $1.73 Million	17,656 Added 110.18%	33,681 $3.31 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $194,338 - $294,641	3,013 Added 23.16%	16,025 $1.22 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $288,664 - $361,180	4,002 Added 44.42%	13,012 $1.15 Million
Q3 2019 Dec 03, 2019	BUY	$62.98 - $75.72 $67,955 - $81,701	1,079 Added 13.6%	9,010 $660,000
Q2 2019 Sep 06, 2019	BUY	$65.7 - $83.98 $16,030 - $20,491	244 Added 3.17%	7,931 $577,000
Q1 2019 May 23, 2019	BUY	$77.14 - $90.79 $34,404 - $40,492	446 Added 6.16%	7,687 $619,000
Q4 2018 Feb 26, 2019	BUY	$77.85 - $96.01 $563,711 - $695,208	7,241 New	7,241 $668,000

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.

Account

Princeton Global Asset Management LLC Abb Vie Inc. Transaction History